Faculty Disclosures
| David R. Lynch, MD, PhD |
The institution of Dr. Lynch has received research support from reata. The institution of Dr. Lynch has received research support from PTC. Dr. Lynch has received intellectual property interests from a discovery or technology relating to health care. |
| Fuki M. Hisama, MD, FAAN |
An immediate family member of Dr. Hisama has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zogenix. The institution of Dr. Hisama has received research support from UW Brotman Baty Precision Medicine Institute. The institution of Dr. Hisama has received research support from NIH/NHGRI. |
| Yasushi Kisanuki, MD, FAAN |
Dr. Kisanuki has nothing to disclose. |
| John R. Guy, MD |
No disclosure on file
|
|
No disclosure on file
|
| Odelia Ghodsizadeh |
No disclosure on file
|
| Vinod Malik |
No disclosure on file
|
| Roula Al-Dahhak, MD |
Dr. Al-Dahhak has nothing to disclose. |
| Wendy M. King, PT |
Ms. King has nothing to disclose. |
| Kumaraswamy Sivakumar, MD, MRCP |
Dr. Sivakumar has nothing to disclose. |
| Glenn T. Stebbins, PhD |
Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Partners Healthcare System. Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CHDI. The institution of Dr. Stebbins has received research support from Department of Defense. Dr. Stebbins has received research support from Cleveland Clinic Health Systems. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Course Director with MDS. |
| Mario Manto, MD, PhD |
No disclosure on file
|
| Massimo Pandolfo, MD, FAAN |
Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Minoryx. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Design Therapeutics . Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Reata. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biomarin. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Design Therapeutics. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. Dr. Pandolfo has stock in Voyager Therapeutics. The institution of Dr. Pandolfo has received research support from Freidreich Ataxaia Research Alliance. Dr. Pandolfo has a non-compensated relationship as a Scientific Advisory Board with Friedreich Ataxia Research Alliance that is relevant to AAN interests or activities. Dr. Pandolfo has a non-compensated relationship as a Member-Meeting Management Committee with AAN that is relevant to AAN interests or activities. |
| Richard J. Barohn, MD, FAAN |
Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care. |
| Brenda Banwell, MD, FAAN |
Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH. |
| Janaiah Kota |
No disclosure on file
|
| Jerry R. Mendell, MD, FAAN |
Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta. |
| Louise R. Rodino-Klapac |
Ms. Rodino-Klapac has received personal compensation for serving as an employee of Sarepta Therapeutics, Inc.. Ms. Rodino-Klapac has received stock or an ownership interest from Sarepta Therapeutics. Ms. Rodino-Klapac has received intellectual property interests from a discovery or technology relating to health care. |
| Zarife Sahenk, MD, PhD, FAAN |
Dr. Sahenk has nothing to disclose. |
| Kevin M. Flanigan, MD, FAAN |
Dr. Flanigan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apic Bio. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AavantiBio. Dr. Flanigan has stock in 4D Molecular Therapeutics. The institution of Dr. Flanigan has received research support from Abeona Therapeutics. The institution of Dr. Flanigan has received research support from Sarepta Therapeutics. The institution of Dr. Flanigan has received research support from Astellas Therapeutics. Dr. Flanigan has received intellectual property interests from a discovery or technology relating to health care. |
| Christopher Shilling, MS |
No disclosure on file
|
| Laurence M. Viollet, PhD |
No disclosure on file
|
| Sarah E. Lewis |
Mrs. Lewis has received personal compensation for serving as an employee of Sarepta Therapeutics . Mrs. Lewis has stock in Sarepta Therapeutics. |
| Christopher Walker, PhD |
No disclosure on file
|
| Hong Yu |
No disclosure on file
|
| Cheryl Wall, CNP |
No disclosure on file
|
| Eli Diamond, MD |
Dr. Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Day One Biopharmaceuticals. Dr. Diamond has received research support from Applebaum Foundation. Dr. Diamond has received research support from Frame Family Fund. Dr. Diamond has received research support from Joy Family West Foundation. |
| David Russell, MD |
No disclosure on file
|